MERONI, MARINA
 Distribuzione geografica
Continente #
AS - Asia 109
EU - Europa 84
NA - Nord America 73
Totale 266
Nazione #
US - Stati Uniti d'America 73
SG - Singapore 70
IT - Italia 32
RU - Federazione Russa 27
HK - Hong Kong 16
CN - Cina 15
FI - Finlandia 6
ID - Indonesia 5
IE - Irlanda 5
SE - Svezia 4
DE - Germania 3
GB - Regno Unito 3
AT - Austria 1
BE - Belgio 1
FR - Francia 1
KR - Corea 1
NL - Olanda 1
PH - Filippine 1
PK - Pakistan 1
Totale 266
Città #
Singapore 65
Santa Clara 23
Hong Kong 16
Milan 14
Shanghai 13
Chandler 7
Dublin 5
Jakarta 5
Arezzo 3
Helsinki 3
Lappeenranta 3
Ashburn 2
Aversa 2
Hounslow 2
Moscow 2
New York 2
Turin 2
Battipaglia 1
Beijing 1
Biella 1
Boardman 1
Buja 1
Caloocan City 1
Carate Brianza 1
Dallas 1
Florence 1
Gatchina 1
Grottaglie 1
Hamm 1
Huizen 1
Islamabad 1
London 1
Louvain-la-Neuve 1
Nuremberg 1
Pavia 1
Seoul 1
Washington 1
Totale 189
Nome #
MSIpixel: a fully automated pipeline for compound annotation and quantitation in mass spectrometry imaging experiments 35
Mechanisms of responsiveness to and resistance against trabectedin in murine models of human myxoid liposarcoma 34
PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical models 24
Establishment and characterization of a new panel of uterine leiomyosarcoma patient-derived xenograft models 24
Abstract 7199: The retinoid X receptor (RXR) agonist IRX4204 potentiates the efficacy of trabectedin and pioglitazone in myxoid liposarcoma preclinical models 23
Chemotherapy-induced neutropenia elicits metastasis formation in mice by promoting proliferation of disseminated tumor cells 21
Betulinic acid and its spray dried microparticle formulation: In vitro PDT effect against ovarian carcinoma cell line and in vivo plasma and tumor disposition 20
The combination of the PPARγ agonist pioglitazone and the RXR agonist IRX4204 induces adipocytic differentiation in myxoid liposarcoma 20
Pharmacokinetics of the combination of trabectedin and pioglitazone in myxoid liposarcoma patient-derived xenograft models 19
Quantitative measurement of pioglitazone in neoplastic and normal tissues by AP-MALDI mass spectrometry imaging 16
Inhibition of tumor-associated macrophages by trabectedin improves the antitumor adaptive immunity in response to anti-PD-1 therapy 16
Enhancing Pt(IV) Complexes' Anticancer Activity upon Encapsulation in Stimuli‐Responsive Nanocages 14
Induction of adipocytic differentiation in myxoid liposarcoma: new approaches to improve the effectiveness of the available therapies 11
Development and Validation of a HPLC–MS/MS Method to Measure Nifuroxazide and Its Application in Healthy and Glioblastoma-Bearing Mice 11
The combination of the PPARγ agonist pioglitazone and the RXR agonist IRX4204 induces adipocytic differentiation in myxoid liposarcoma. 10
Corrigendum to “Mechanisms of responsiveness to and resistance against trabectedin in murine models of human myxoid liposarcoma” [Genomics Volume 113, Issue 5, September 2021, Pages 3439–3448] (Genomics (2021) 113(5) (3439–3448), (S0888754321003062), (10.1016/j.ygeno.2021.07.028)) 9
Distribution of pamiparib, a novel inhibitor of poly(ADP-ribose)-polymerase (PARP), in tumor tissue analyzed by multimodal imaging 8
Pharmacokinetic evaluation of trabectedin and pioglitazone combination in myxoid liposarcoma patient-derived xenografts. 6
Totale 321
Categoria #
all - tutte 2.172
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.172


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202317 1 1 1 3 2 4 0 3 2 0 0 0
2023/2024123 0 1 0 7 4 5 33 12 12 2 6 41
2024/2025181 38 94 49 0 0 0 0 0 0 0 0 0
Totale 321